Heritage Cannabis Holdings (CANN.C) signed into a supply agreement with IntelGenx (IGX.V) to manufacture and supply filmstrip products containing 10 mg of CBD for the Canadian and Australian markets, using IntelGenx’s VersaFilm today, according to a press release.
The company placed its first purchase order with IntelGenx for 50,000 CBD filmstrips to be sold in provincial retailers and direct-to-consumer medical channels in Canada. The filmstrips are formulated with both CBD and CBDA. In published studies, CBDA has shown more efficacy with serotonin receptors in the brain.
“Rapidly dissolving CBD Filmstrips provide tangible benefits for medical cannabis consumers by providing a more discreet and convenient administration method. As we continue to build a wide spectrum of medical cannabis products that offer both traditional and newer delivery platforms, we are excited to be at the stage where we will be distributing CBD Filmstrips in Canada and Australia,” said Umar Syed, Heritage’s president of the medical and international division.
Heritage is up 3.6% on the day and presently trading at $0.145.
Full disclosure: Heritage Cannabis Holdings is an equity.guru marketing client.